Psychiatric Times February 28, 2025
Check out the pipeline updates from February!
This month, there were a few important developments in the psychiatric treatment pipeline. We compiled a recap of the latest news here, just in case you missed any of the updates.
Targeting the Brain: A New Path Forward for IBS Treatment
A new study shows that opioid delta-receptor (DOP) agonists target the central nervous system, potentially alleviating irritable bowel syndrome (IBS) symptoms linked to psychological stress. A novel animal model demonstrated that DOP agonists regulate glutamate neurotransmission in the insular cortex, improving IBS symptoms. This suggests that DOP agonists may offer a more definitive IBS treatment with minimal adverse effects compared with current therapeutic options.
CYB003 for the Adjunctive Treatment of Major Depressive...
Today's Sponsors
Today's Sponsor